Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6249 | 1444 | 44.4 | 71% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | Journal | 47 | 19% | 15% | 217 |
| 2 | CHRISTIAN SARKINE AUTISM TREATMENT | Address | 16 | 58% | 1% | 18 |
| 3 | NISONGER | Address | 8 | 20% | 2% | 35 |
| 4 | BUR CHILDREN FAMILIES | Address | 6 | 80% | 0% | 4 |
| 5 | NISONGER MENTAL RETARDAT DEV DISABIL | Address | 4 | 67% | 0% | 4 |
| 6 | PEDIATRIC PSYCHOPHARMACOLOGY | Author keyword | 4 | 44% | 0% | 7 |
| 7 | NISONGER UCEDD | Address | 4 | 41% | 0% | 7 |
| 8 | CLIN POLYCLIN CHILD ADOLESCENT PSYCHIAT | Address | 3 | 100% | 0% | 3 |
| 9 | MERCK PROGRAM | Address | 3 | 60% | 0% | 3 |
| 10 | SEAVER NEW YORK AUTISM EXCELLENCE | Address | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SUBAVERAGE INTELLIGENCE | 59 | 81% | 2% | 35 |
| 2 | PERVASIVE DEVELOPMENTAL DISORDERS | 29 | 10% | 19% | 272 |
| 3 | PEDIATRIC PSYCHOPHARMACOLOGY | 20 | 48% | 2% | 31 |
| 4 | DISRUPTIVE BEHAVIOR DISORDERS | 19 | 19% | 6% | 93 |
| 5 | LONG TERM RISPERIDONE | 18 | 89% | 1% | 8 |
| 6 | AUTISTIC DISORDER | 17 | 23% | 5% | 67 |
| 7 | SCHIZOPHRENIC CHILDREN | 17 | 47% | 2% | 26 |
| 8 | PSYCHOACTIVE MEDICINES | 16 | 64% | 1% | 16 |
| 9 | CHILDHOOD ONSET SCHIZOPHRENIA | 16 | 17% | 6% | 90 |
| 10 | 2ND GENERATION ANTIPSYCHOTICS | 16 | 16% | 6% | 93 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 47 | 19% | 15% | 217 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders | 2011 | 71 | 48 | 73% |
| Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders | 2014 | 6 | 47 | 96% |
| Corrected QT Changes During Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials | 2015 | 2 | 81 | 48% |
| The Pharmacological Management of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents With Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, and Conduct Disorder: A Systematic Review and Meta-Analysis. Part 2: Antipsychotics and Traditional Mood Stabilizers | 2015 | 1 | 30 | 77% |
| Psychotropic Medications in Children with Autism Spectrum Disorders: A Systematic Review and Synthesis for Evidence-Based Practice | 2012 | 24 | 41 | 83% |
| Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic Review | 2012 | 23 | 12 | 83% |
| Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice | 2011 | 73 | 104 | 49% |
| Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia | 2014 | 8 | 41 | 49% |
| Pharmacotherapy to control behavioral symptoms in children with autism | 2012 | 14 | 99 | 89% |
| Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies | 2011 | 34 | 115 | 63% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHRISTIAN SARKINE AUTISM TREATMENT | 16 | 58% | 1.2% | 18 |
| 2 | NISONGER | 8 | 20% | 2.4% | 35 |
| 3 | BUR CHILDREN FAMILIES | 6 | 80% | 0.3% | 4 |
| 4 | NISONGER MENTAL RETARDAT DEV DISABIL | 4 | 67% | 0.3% | 4 |
| 5 | NISONGER UCEDD | 4 | 41% | 0.5% | 7 |
| 6 | CLIN POLYCLIN CHILD ADOLESCENT PSYCHIAT | 3 | 100% | 0.2% | 3 |
| 7 | MERCK PROGRAM | 3 | 60% | 0.2% | 3 |
| 8 | SEAVER NEW YORK AUTISM EXCELLENCE | 3 | 60% | 0.2% | 3 |
| 9 | CLIN NEUROSCI PEDIAT | 2 | 38% | 0.3% | 5 |
| 10 | BIOPOLAR DISORDERS | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000262538 | PREMORBID DEVELOPMENT//CHILDHOOD ONSET SCHIZOPHRENIA//BRIEF PSYCHIATRIC RATING SCALE FOR CHILDREN |
| 2 | 0.0000152675 | PEDIATRIC BIPOLAR DISORDER//JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY//JOHNSON JOHNSON STUDY PEDIAT PSYCHOPATHOL |
| 3 | 0.0000145096 | JOURNAL OF INTELLECTUAL DISABILITY RESEARCH//INTELLECTUAL DISABILITY//INTELLECTUAL DISABILITIES |
| 4 | 0.0000133480 | SOUR CHERRY SEED EXTRACT//SOUR CHERRY KERNEL//ANTI PSYCHOTIC DRUG |
| 5 | 0.0000110310 | WS HALL PSYCHIAT//BROAD AUTISM PHENOTYPE//HYPERSEROTONEMIA |
| 6 | 0.0000103260 | ATTENTION DEFICIT HYPERACTIVITY DISORDER//METHYLPHENIDATE//ADHD |
| 7 | 0.0000084881 | JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS//AUTISM//AUTISM SPECTRUM DISORDERS |
| 8 | 0.0000073655 | THIMEROSAL//NIEHS CHILDRENS ENVIRONM HLTH//SHAIK AL AMODI AUTISM CHAIR |
| 9 | 0.0000070559 | BTBR//BTBR T PLUS TF J//BTBR MICE |
| 10 | 0.0000058878 | CLOZAPINE//RISPERIDONE//OLANZAPINE |